Chan, Ariane
Singh, A. Jonathan
Northcote, Peter T.
Miller, John H.
Funding for this research was provided by:
Cancer Society of New Zealand (E1807)
Wellington Medical Research Foundation (E1707)
Genesis Oncology Trust
Article History
Received: 22 March 2016
Accepted: 27 April 2016
First Online: 7 May 2016
Compliance with ethical standards
:
: Peter Northcote and John Miller are named on a patent for use of peloruside A as an anticancer agent.